title: Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.
abstract: Primary graft dysfunction (PGD) is a common early complication after lung transplantation. We conducted a retrospective cohort study of 334 recipients to evaluate the impact of PGD graded at 24, 48 and 72 h on the risk of bronchiolitis obliterans syndrome (BOS) development (stage 1) and progression (stages 2 and 3). We constructed multivariable Cox proportional hazards models to determine the risk of BOS attributable to PGD in the context of other potential risk factors including acute rejection, lymphocytic bronchitis and respiratory viral infections. All grades of PGD at all time points were significant risk factors for BOS development and progression independent of acute rejection, lymphocytic bronchitis and respiratory viral infections. Specifically, PGD grade 1 at T24 was associated with a relative risk of BOS stage 1 of 1.93, grade 2 with a relative risk of 2.29 and grade 3 with a relative risk of 3.31. Furthermore, this direct relationship between the severity of PGD and the risk of BOS persisted at all time points. We conclude that all grades of PGD at all time points are independent risk factors for BOS development and progression. Future strategies that might attenuate the severity of PGD may mitigate the risk of BOS.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: H J
authors.initials: HJ
authors.lastname: Huang
authors.forename: R D
authors.initials: RD
authors.lastname: Yusen
authors.forename: B F
authors.initials: BF
authors.lastname: Meyers
authors.forename: M J
authors.initials: MJ
authors.lastname: Walter
authors.forename: T
authors.initials: T
authors.lastname: Mohanakumar
authors.forename: G A
authors.initials: GA
authors.lastname: Patterson
authors.forename: E P
authors.initials: EP
authors.lastname: Trulock
authors.forename: R R
authors.initials: RR
authors.lastname: Hachem
mesh_terms: D001989:Bronchiolitis Obliterans / Q000628:therapy*; D015331:Cohort Studies; D018450:Disease Progression; D005260:Female; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects* / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D055031:Primary Graft Dysfunction / Q000628:therapy*; D012189:Retrospective Studies; D012306:Risk; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
references.citation: Ann Thorac Surg. 1996 Sep;62(3):866-72
references.pmid: 8784021
references.citation: Proc Am Thorac Soc. 2006 Jul;3(5):444-9
references.pmid: 16799090
references.citation: Am J Respir Crit Care Med. 2007 Mar 1;175(5):507-13
references.pmid: 17158279
references.citation: Am J Transplant. 2006 Aug;6(8):1799-808
references.pmid: 16889540
references.citation: J Immunol. 2008 Apr 1;180(7):4487-94
references.pmid: 18354170
references.citation: J Heart Lung Transplant. 2002 Mar;21(3):297-310
references.pmid: 11897517
references.citation: J Thorac Cardiovasc Surg. 2006 Jan;131(1):73-80
references.pmid: 16399297
references.citation: J Heart Lung Transplant. 1993 Sep-Oct;12(5):713-6
references.pmid: 8241207
references.citation: Am J Respir Crit Care Med. 2004 Jul 15;170(2):181-7
references.pmid: 15130908
references.citation: J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):1-15
references.pmid: 8820078
references.citation: Int J Biochem Cell Biol. 1995 Aug;27(8):775-82
references.pmid: 7584611
references.citation: Am J Respir Crit Care Med. 2005 Jun 1;171(11):1312-6
references.pmid: 15764726
references.citation: J Heart Lung Transplant. 2005 Oct;24(10):1451-3
references.pmid: 16210115
references.citation: Eur J Cardiothorac Surg. 2007 Jan;31(1):75-82
references.pmid: 17134909
references.citation: J Immunol. 2006 Oct 15;177(8):5631-8
references.pmid: 17015751
references.citation: Transplantation. 2007 Jan 27;83(2):150-8
references.pmid: 17264811
references.citation: J Immunol. 2002 Aug 1;169(3):1542-9
references.pmid: 12133982
references.citation: Am J Transplant. 2003 Sep;3(9):1155-66
references.pmid: 12919096
references.citation: Am J Transplant. 2005 Jan;5(1):131-8
references.pmid: 15636621
references.citation: Am J Transplant. 2006 Apr;6(4):724-35
references.pmid: 16539629
references.citation: Am J Respir Crit Care Med. 2003 Feb 15;167(4):490-511
references.pmid: 12588712
references.citation: J Heart Lung Transplant. 2006 Apr;25(4):371-8
references.pmid: 16563963
references.citation: Am J Surg Pathol. 1993 May;17(5):491-6
references.pmid: 8470763
references.citation: Eur Respir J. 2005 Mar;25(3):494-501
references.pmid: 15738294
references.citation: Hum Pathol. 1980 Jul;11(4):353-66
references.pmid: 6997183
references.citation: Transplantation. 2002 Sep 27;74(6):799-804
references.pmid: 12364858
references.citation: J Thorac Cardiovasc Surg. 1998 Nov;116(5):812-20
references.pmid: 9806388
references.citation: Hum Immunol. 2003 May;64(5):521-9
references.pmid: 12691702
references.citation: J Heart Lung Transplant. 1996 Jul;15(7):709-14
references.pmid: 8820787
references.citation: Transplantation. 2005 Nov 27;80(10):1406-13
references.pmid: 16340783
references.citation: J Heart Lung Transplant. 2005 Oct;24(10):1454-9
references.pmid: 16210116
references.citation: J Heart Lung Transplant. 2007 Oct;26(10):1004-11
references.pmid: 17919620